Daxor Corporation (DXR) Insider Trading Activity
NASDAQ$7.3
Market Cap
$35.31M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
325 of 877
Rank in Industry
22 of 46
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
DXR Insider Trading Activity
DXR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $50,082 | 5 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Feldschuh Michael Richard | Chief Executive Officer | 3 | $42,082 | 0 | $0 | $42,082 |
| Michel Robert J | Chief Financial Officer | 1 | $8,000 | 0 | $0 | $8,000 |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 1 | $0 | 0 | $0 | $0 |
About Daxor Corporation
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Insider Activity of Daxor Corporation
Over the last 12 months, insiders at Daxor Corporation have bought $50,082 and sold $0 worth of Daxor Corporation stock.
On average, over the past 5 years, insiders at Daxor Corporation have bought $58,205 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Feldschuh Michael Richard (Chief Executive Officer) — $42,082. Michel Robert J (Chief Financial Officer) — $8,000.
The last purchase of 2,063 shares for transaction amount of $16,277 was made by Feldschuh Michael Richard (Chief Executive Officer) on 2025‑04‑04.
List of Insider Buy and Sell Transactions, Daxor Corporation
| 2025-04-04 | Feldschuh Michael Richard | Chief Executive Officer | 2,063 0.044% | $7.89 | $16,277 | -1.90% | ||
| 2025-03-10 | Feldschuh Michael Richard | Chief Executive Officer | 3,360 0.0688% | $7.68 | $25,805 | +0.52% | ||
| 2025-03-10 | Michel Robert J | Chief Financial Officer | 1,000 0.0213% | $8.00 | $8,000 | +0.52% | ||
| 2024-12-06 | Feldschuh Michael Richard | Chief Executive Officer | 45,000 – | $0 | $0 | -12.26% | ||
| 2024-12-06 | Feldschuh Jonathan Adam | Chief Scientific Officer | 32,000 – | $0 | $0 | -12.26% | ||
| 2024-03-27 | Michel Robert J | Chief Financial Officer | 750 0.0161% | $8.70 | $6,525 | +3.15% | ||
| 2024-03-26 | Feldschuh Michael Richard | Chief Executive Office | 1,000 0.0199% | $8.13 | $8,130 | +2.43% | ||
| 2024-03-19 | Feldschuh Michael Richard | Chief Executive Officer | 647 0.0133% | $8.15 | $5,273 | +5.60% | ||
| 2024-03-10 | Feldschuh Michael Richard | Chief Executive Officer | 1,492 0.0308% | $7.72 | $11,518 | +7.52% | ||
| 2024-03-04 | Feuer Edward | director | 1,000 0.0212% | $7.21 | $7,210 | +23.37% | ||
| 2023-12-06 | Michel Robert J | Chief Financial Officer | 120 0.0025% | $7.75 | $930 | +12.14% | ||
| 2023-12-01 | Feldschuh Michael Richard | Chief Executive Officer | 800 0.0166% | $7.80 | $6,240 | +13.63% | ||
| 2023-12-01 | Michel Robert J | Chief Financial Officer | 180 0.0037% | $7.75 | $1,395 | +13.63% | ||
| 2023-11-24 | Michel Robert J | Chief Financial Officer | 500 0.0104% | $7.94 | $3,970 | +12.09% | ||
| 2023-11-10 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | 1,001 0.021% | $7.83 | $7,838 | +13.97% | ||
| 2023-11-09 | Feldschuh Michael Richard | CHIEF EXECUTIVE OFFICER | 401 0.0082% | $7.85 | $3,148 | +11.61% | ||
| 2023-10-13 | Michel Robert J | Chief Financial Officer | 500 0.0106% | $9.02 | $4,510 | -0.67% | ||
| 2023-05-24 | Feldschuh Michael Richard | CEO & President | 2,000 0.0494% | $9.75 | $19,500 | -1.14% | ||
| 2023-05-24 | Goudie Joy S. | director | 300 0.0074% | $9.75 | $2,925 | -1.14% | ||
| 2023-03-27 | Michel Robert J | Chief Financial Officer | 4,750 – | $0 | $0 | -14.69% |
Total: 220
*Gray background shows transactions not older than one year
Insider Historical Profitability
26.18%
| Feldschuh Michael Richard | Chief Executive Officer | 212694 4.3973% | $1.55M | 37 | 1 | +6.75% |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 35908 0.7424% | $262,128.40 | 1 | 1 | |
| Michel Robert J | Chief Financial Officer | 17050 0.3525% | $124,465.00 | 11 | 0 | +27.82% |
| FELDSCHUH JOSEPH | 10 percent owner | 2774455 57.3598% | $20.25M | 105 | 3 | +24.27% |
| Hudson Philip Nordan | director | 146200 3.0226% | $1.07M | 13 | 0 | |
| WILLENS ROBERT | director | 18164 0.3755% | $132,597.20 | 17 | 0 | +21.24% |
| WOLPOFF MARTIN S | director | 4000 0.0827% | $29,200.00 | 8 | 2 | +18.35% |
| DesRosiers Caleb | director | 3157 0.0653% | $23,046.10 | 1 | 0 | |
| Thompson Soren | VP, Business Development | 1950 0.0403% | $14,235.00 | 2 | 1 | +54.72% |
| MOUSSA ROBERT G | director | 1000 0.0207% | $7,300.00 | 2 | 0 | |
| Feuer Edward | director | 1000 0.0207% | $7,300.00 | 2 | 0 | +30.13% |
| LOMBARD JAMES A | director | 500 0.0103% | $3,650.00 | 1 | 0 | |
| Valentine Stephen | director | 500 0.0103% | $3,650.00 | 1 | 0 | |
| Meegan Diane Marie | Corporate Secretary | 500 0.0103% | $3,650.00 | 1 | 1 | |
| Engstrom Everis | Vice President | 500 0.0103% | $3,650.00 | 1 | 0 | |
| Goudie Joy S. | director | 300 0.0062% | $2,190.00 | 1 | 0 | |
| Saxe Bernhard | director | 200 0.0041% | $1,460.00 | 1 | 0 | |
| SLOVIN BRUCE | director | 0 0% | $0 | 0 | 6 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
Daxor Corporation (DXR) | $117,413 | 7 | 26.18% | $35.31M |
DXR Institutional Investors: Active Positions
| Increased Positions | 5 | +71.43% | 15,952 | +17.64% |
| Decreased Positions | 2 | -28.57% | 600 | -0.66% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 2 | Sold Out | 600 | Sold Out |
| Total Postitions | 10 | +42.86% | 105,783 | +16.98% |
DXR Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $368.00 | 0.98% | 48,828 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $209.00 | 0.56% | 27,821 | +13,000 | +87.71% | 2024-12-31 |
| Keyes, Stange & Wooten Wealth Management, Llc | $110.00 | 0.29% | 14,612 | 0 | 0% | 2024-12-31 |
| Osaic Holdings, Inc. | $54.00 | 0.14% | 7,200 | 0 | 0% | 2024-12-31 |
| Sbi Securities Co., Ltd. | $24.00 | 0.06% | 3,128 | 0 | 0% | 2025-03-31 |
| Ubs Group Ag | $20.00 | 0.05% | 2,599 | +1,363 | +110.28% | 2024-12-31 |
| Morgan Stanley | $1.00 | <0.01% | 88 | +87 | +8,700% | 2024-12-31 |
| Jpmorgan Chase & Co | $0 | 0% | 5 | 0 | 0% | 2024-12-31 |
| Jones Financial Companies Lllp | $0 | 0% | 0 | -100 | Sold Out | 2024-12-31 |
| Princeton Global Asset Management Llc | $0 | 0% | 0 | -500 | Sold Out | 2025-03-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.